Nanomedicine is expected to become the next big thing in the pharmaceutical sector. The total market for nanomedicine is projected to grow at a compound annual growth rate (CAGR) of 16.3% from 2014 through 2019 and reach $528 billion by 2019. Compared to the overall pharmaceuticals market, the nanopharmaceuticals market is expected to grow its share from 14.7% in 2014 to 22.1% by the year 2019.

However, in order to accelerate the development of nanomedicine there are some key aspects that the scientific community needs to discuss about, i.e. regulatory aspects, GMP manufacturing, standardization and characterization. The 2nd Workshop on Translational Nanomedicine will bring together experts to debate about these key issues in five sessions:

• Session 1: Research in Nanomedicine in early stage of development – how to be prepared for translational research.
• Session 2: Microfluidics  technology  applied  to  nanoformulation
• Session 3: Research in Nanomedicine in early stage of development II
• Session 4: Advanced characterisation techniques
• Session 5: Nanomedicine and regulatory environment for nano-investigational medicinal products.

Share: